Peroxisomal disorders: clinical aspects.
Peroxisomal disorders are divided into two groups from a clinical point of view. Diseases in the first group, peroxisome-deficient disorders (PDD), Zellweger-like syndrome, and isolated deficiencies of peroxisomal beta-oxidation enzymes, are characterized by common clinical features including psychomotor retardation, hypotonia, hepatic dysfunction and visual disturbance. The second group includes diseases with a unique manifestation, such as X-linked adrenoleukodystrophy, hyperoxaluria type I and rhizomelic chondrodysplasia punctata. We investigated clinical aspects and the genetic basis of PDD, and the significance of peroxisomes in the development of human brain. Neuroradiological and neurophysiological studies revealed that thick cortex, colpocephaly and multifocal spikes were characteristic findings of PDD patients in the early infantile period. Cytogenetic studies elucidated the presence of eleven complementation groups among PDD, indicating the presence of eleven pathogenic genes for PDD. Molecular studies elucidated two of these genes, PAF-1 and PXR-1. Immunohistochemical studies clarified that the catalase-positive neurons appeared in the basal ganglia, thalamus, and cerebellum at 28 weeks of gestation, and in the cortex at 35 weeks. Immunopositive glial cells appeared from the deep to superficial white matter with increasing gestational age. These results suggest the important role of peroxisomes in neuronal maturation and myelinogenesis.
Suzuki
Y
Y
Department of Pediatrics, Gifu University School of Medicine, Japan.
Shimozawa
N
N
Takahashi
Y
Y
Imamura
A
A
Kondo
N
N
Orii
T
T
D001921:Brain / Q000254:growth & development; D002374:Catalase / Q000378:metabolism; D005816:Genetic Complementation Test; D006801:Humans; D007150:Immunohistochemistry; D018901:Peroxisomal Disorders / Q000235:genetics / Q000503:physiopathology*
D002374:Catalase